NSE - Delayed Quote INR

Divi's Laboratories Limited (DIVISLAB.NS)

Compare
5,771.35
-53.20
(-0.91%)
At close: January 10 at 3:29:59 PM GMT+5:30
Loading Chart for DIVISLAB.NS
DELL
  • Previous Close 5,824.55
  • Open 5,800.00
  • Bid --
  • Ask --
  • Day's Range 5,715.20 - 5,840.00
  • 52 Week Range 3,350.00 - 6,285.45
  • Volume 384,412
  • Avg. Volume 502,405
  • Market Cap (intraday) 1.532T
  • Beta (5Y Monthly) 0.35
  • PE Ratio (TTM) 83.33
  • EPS (TTM) 69.26
  • Earnings Date Feb 8, 2025 - Feb 12, 2025
  • Forward Dividend & Yield 30.00 (0.52%)
  • Ex-Dividend Date Aug 2, 2024
  • 1y Target Est 5,560.41

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

www.divislabs.com

9,741

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DIVISLAB.NS

View More

Performance Overview: DIVISLAB.NS

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

DIVISLAB.NS
4.53%
S&P BSE SENSEX
1.11%

1-Year Return

DIVISLAB.NS
45.73%
S&P BSE SENSEX
8.39%

3-Year Return

DIVISLAB.NS
31.65%
S&P BSE SENSEX
29.52%

5-Year Return

DIVISLAB.NS
226.31%
S&P BSE SENSEX
86.67%

Compare To: DIVISLAB.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DIVISLAB.NS

View More

Valuation Measures

As of 1/10/2025
  • Market Cap

    1.53T

  • Enterprise Value

    1.50T

  • Trailing P/E

    83.46

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    17.89

  • Price/Book (mrq)

    11.17

  • Enterprise Value/Revenue

    17.47

  • Enterprise Value/EBITDA

    51.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    21.31%

  • Return on Assets (ttm)

    9.12%

  • Return on Equity (ttm)

    13.91%

  • Revenue (ttm)

    86.14B

  • Net Income Avi to Common (ttm)

    18.36B

  • Diluted EPS (ttm)

    69.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.02B

  • Total Debt/Equity (mrq)

    0.06%

  • Levered Free Cash Flow (ttm)

    3.82B

Research Analysis: DIVISLAB.NS

View More

People Also Watch